ClearPoint Neuro, Inc. (CLPT)

NASDAQ: CLPT · IEX Real-Time Price · USD
+0.05 (0.63%)
Mar 27, 2023, 4:30 PM EDT - Market closed

Company Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States.

The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance.

It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite.

It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco.

The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020.

ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro, Inc.
ClearPoint Neuro logo
Country United States
Founded 1998
Industry Medical Devices
Sector Healthcare
Employees 80
CEO Mr. Joseph Michael Burnett

Contact Details

120 S. Sierra Avenue, Suite 100
Solana Beach, California 92075
United States
Phone (949) 900-6833

Stock Details

Ticker Symbol CLPT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001285550
CUSIP Number 18507C103
ISIN Number US18507C1036
Employer ID 58-2394628
SIC Code 3841

Key Executives

Name Position
Joseph Michael Burnett President, Chief Executive Officer and Director
Danilo D'Alessandro Chief Financial Officer
Mazin Sabra Chief Operating Officer
Ellisa Cholapranee General Counsel and Secretary
Jacqueline Keller Vice President of Marketing

Latest SEC Filings

Date Type Title
Mar 3, 2023 8-K Current Report
Mar 1, 2023 10-K Annual Report
Mar 1, 2023 8-K Current Report
Feb 9, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 11, 2023 8-K Current Report
Dec 14, 2022 8-K Current Report
Nov 8, 2022 10-Q Quarterly Report
Nov 8, 2022 8-K Current Report
Nov 7, 2022 8-K Current Report
Sep 20, 2022 8-K Current Report